Ardent Health, Inc.
ARDTNYSEHealthcare · Services-General Medical & Surgical Hospitals, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | $6.32B | $5.97B | $5.41B | $5.13B |
| Operating income | — | — | — | — |
| Net income | $135.8M | $210.3M | $53.9M | $188.9M |
| Total assets | $5.29B | $4.96B | $4.73B | — |
| Total liabilities | $3.61B | $3.43B | $3.65B | — |
| Equity | $1.29B | $1.13B | $670.9M | $1.04B |
| EPS (diluted) | $0.96 | $1.58 | $0.43 | $1.50 |
| Shares out. | 142.8M | 142.7M | 0 | 126.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 2.1%
- Return on equity
- 10.5%
- Return on assets
- 2.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 68.1%
- Debt / equity
- 2.80×
- Book value / share
- $9.02
- Revenue growth (YoY)
- 6.0%
- Net income growth (YoY)
- −35.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −6.3%clean
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 good- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.9M | 6.0 | -7.3% |
| Apr 30, 2026 | 3.1M | 8.7 | +5.8% |
| Apr 15, 2026 | 2.9M | 9.3 | +3.1% |
| Mar 31, 2026 | 2.8M | 7.8 | +2.3% |
| Mar 13, 2026 | 2.8M | 6.2 | +4.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 26, 2026
- Results of operationsMay 5, 2026
- Director / officer changeMar 27, 2026
- Results of operationsMar 4, 2026
- Regulation FD disclosure · Other material eventNov 18, 2025
- Results of operationsNov 12, 2025
- Entered a material agreement · New financial obligationSep 23, 2025
- Results of operationsAug 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.